NEW HIGHLIGHT
Trezilent

Trezilent Indications/Uses

Manufacturer:

Novartis

Distributor:

DKSH
Full Prescribing Info
Indications/Uses
TREZILENT is indicated in combination with fulvestrant for the treatment of postmenopausal women, and men, with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, PIK3CA-mutated, advanced or metastatic breast cancer following progression on or after an endocrine-based regimen.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in